Clinical Trials Sponsored by Leidos Life Sciences

Total 859 results

Leidos Life Sciences
United States Department of Defense

Active, not recruiting

LEAP-CT for Treatment of COVID-19 Patients (Master Protocol)

COVID-19 | Covid19 | Coronavirus Disease 2019 | SARS-CoV-2 Infection | SARS-CoV-2 Acute Respiratory Disease | COVID-19 Pandemic | COVID-19 Virus Infection | COVID-19 Virus Disease | 2019 Novel Coronavirus Disease | 2019 Novel Coronavirus Infection | 2019-nCoV Disease | 2019-nCoV Infection

United States
Leidos Life Sciences
United States Department of Defense

Withdrawn

Leidos-Enabled Adaptive Protocol for Clinical Trials (LEAP-CT) in Hospitalized Patients With COVID-19 (Addendum 1)

COVID-19 | Covid19 | Coronavirus Disease 2019 | SARS-CoV-2 Infection | SARS-CoV-2 Acute Respiratory Disease | COVID-19 Pandemic | COVID-19 Virus Infection | COVID-19 Virus Disease | 2019 Novel Coronavirus Disease | 2019 Novel Coronavirus Infection | 2019-nCoV Disease | 2019-nCoV Infection
Leidos Life Sciences
United States Department of Defense

Terminated

Leidos-Enabled Adaptive Protocol (LEAP-CT) for Evaluation of Post-exposure Prophylaxis for Newly-infected COVID-19 Patients (Addendum 2)

COVID-19 | Covid19 | Coronavirus Disease 2019 | SARS-CoV2 Infection | SARS-CoV-2 Acute Respiratory Disease | COVID-19 Pandemic | COVID-19 Virus Infection | COVID-19 Virus Disease | 2019 Novel Coronavirus Disease | 2019 Novel Coronavirus Infection | 2019-nCoV Disease | 2019-nCoV Infection

United States
Nimble Science Ltd.
IGY Life Sciences

Recruiting

Evaluation of the Microbiome in Multiple Sclerosis

Multiple Sclerosis

Canada
Halucenex Life Sciences Inc.
KGK Science Inc.

Active, not recruiting

Investigating the Therapeutic Effects of Psilocybin in Treatment-Resistant Post-Traumatic Stress Disorder

Post Traumatic Stress Disorder | Treatment Resistant Disorders

Canada
SK Life Science, Inc.
PRA Health Sciences

Completed

Bioavailability and Food Effect Study of 3 Types of Carisbamate

Healthy Subjects

United States
Vigonvita Life Sciences

Recruiting

Long-term Safety of TPN171H Tablet in Erectile Dysfunction.

Erectile Dysfunction

China
Vigonvita Life Sciences

Recruiting

Safety and Pharmacokinetics Study of Multiple Ascending Doses and Food Effect of LV232 Capsules

Healthy Subjects

China
Vigonvita Life Sciences

Recruiting

Study of the Safety, Tolerability, Pharmacokinetics and Food Effects of VV119 Capsules in Chinese Healthy Volunteers

Schizophrenia

China
Recognify Life Sciences

Recruiting

A Study to Evaluate RL-007 in the Treatment of Cognitive Impairment Associated With Schizophrenia (CIAS)

Schizophrenia | Cognitive Impairment | Cognitive Impairment Associated With Schizophrenia (CIAS)

United States
Achieve Life Sciences

Completed

A Study of Cytisinicline for Vaping Cessation in Adult Smokers (ORCA-V1)

Vaping | E-Cig Use

United States
Achieve Life Sciences

Completed

Study to Evaluate Effect of Food on Bioavailability of Single 3 mg Tablet and Pharmacokinetics (PK) of Multiple 3 mg Doses in Healthy Adult Smokers

Smoking Cessation

Portugal
Rediscovery Life Sciences

Active, not recruiting

Study of Suramin in Subjects With Furosemide-Resistant AKI

Acute Kidney Injury

United States
Vigonvita Life Sciences

Completed

Evaluate the Effect of TPN171H on the QT/QTc Interval in Healthy Volunteers

Healthy Subjects

China
Achieve Life Sciences

Completed

A Study of Cytisinicline for Smoking Cessation in Adult Smokers (ORCA-2)

Smoking Cessation

United States
Cymra Life Sciences

Completed

A Study of Cybis™ 10:25 THC:CBD Oil in Adults With Chronic Back/Neck Pain (CYDEPS)

Pain | Back Pain | Chronic Pain | Neck Pain | Pain, Chronic | CBD | Pain, Back | Pain, Neck | THC

Australia
Vigonvita Life Sciences

Completed

Safety and Pharmacokinetics Study of Single Ascending Doses of VV116 in Healthy Volunteers

Healthy Subjects

China
Recognify Life Sciences

Completed

Safety, Biomarker Study of RL-007 in Subjects With Schizophrenia

Schizophrenia | Cognitive Impairment

United States
Wako Life Sciences

Unknown

A Protocol of the Canadian Prospective Study for Hepatocellular Carcinoma Surveillance Using Biomarkers

Cirrhosis | Chronic Liver Diseases

Canada
LG Life Sciences

Completed

Study to Assess the Efficacy and Safety of Eutropin in Prader-Willi Syndrome

Prader-Willi Syndrome

Korea, Republic of
LG Life Sciences

Completed

Observational Study to Evaluate Long-term Safety and Biodegradability of YVOIRE Volume s

Correction of Nasolabial Folds
LG Life Sciences

Completed

Observational Study to Evaluate Long-term Safety and Biodegradability of YVOIRE Classic s

Correction of Nasolabial Folds

China
LG Life Sciences

Completed

An Observational Study to Evaluate Cardiovascular Outcomes of T2DM PatientsTreated With Gemigliptin

Type 2 Diabetes Mellitus

Korea, Republic of
LG Life Sciences

Completed

Evaluation of the Ease of Use, Preference, and Safety of EutropinPen Inj.

Growth Hormone Deficiency | Chronic Renal Failure | Turner Syndrome | Infant, Small for Gestational Age | Short Stature, Idiopathic

Korea, Republic of
LG Life Sciences

Completed

Study of LC23-1306 in Healthy Male Subjects

Acute Coronary Syndrome

Korea, Republic of
LG Life Sciences

Completed

A Study to Evaluate the Long-term Safety and Efficacy of LBEC0101 in Subjects With Active RA Despite Methotrexate (MTX)

Rheumatoid Arthritis

Korea, Republic of
LG Life Sciences

Completed

Trial to Evaluate the Efficacy and Safety of Gemigliptin Compared With Placebo Added on Insulin Alone or on Insulin in Combination With Metformin in Type 2 DM (ZEUS II Study)

Type 2 Diabetes Mellitus
Transparency Life Sciences

Unknown

Endpoint Calibration for a Phase 2 Study of Lisinopril in Multiple Sclerosis

Multiple Sclerosis, Relapsing-Remitting

United States
Genzum Life Sciences

Completed

BE Study of Naftifine HCL

Tinea Pedis

United States, Dominican Republic
LG Life Sciences

Completed

Gemigliptin-Rosuvastatin Fix-dose Combination Phase 3(BALANCE)

Type 2 Diabetes | Dyslipidemia

Korea, Republic of
LG Life Sciences

Unknown

Study to Evaluate the Efficacy, Safety and PK of Intravenous Single Injection LC28-0126 Immediately Before PCI in STEMI Patients

ST-segment Elevation Myocardial Infarction

Korea, Republic of
LG Life Sciences

Completed

Phase 2 Study to Evaluate the Efficacy, Safety and PK of Intravenous Single Injection LC28-0126 Immediately Before PCI in STEMI Patients

ST-segment Elevation Myocardial Infarction

Korea, Republic of
LG Life Sciences

Unknown

Observational Study to Evaluate the Safety and Efficacy for Levacalm Tab. Versus Valsartan/Amlodipine Combination Therapy in Essential Hypertension Patients

Orthostatic Hypertension | Lower Leg Edema

Korea, Republic of
Integrity Life Sciences

Completed

Assessment of Activities of Daily Living in Adults With Chronic Low Back Pain Using a Nonoperative Treatment Modality

Low Back Pain
LG Life Sciences

Completed

A Phase IIIb Study to Evaluate the Safety and Efficacy of Gemigliptin in Type 2 Diabetes Mellitus Patients With Moderate or Severe Renal Impairment(GUARD Study) (GUARD)

Type 2 DM Patients With Moderate or Severe Renal Impairment

Korea, Republic of
LG Life Sciences

Completed

Bioequivalence of a Single Subcutaneous Dose of BEPO and REPO in Healthy Male Subjects

Healthy
LG Life Sciences

Completed

Multicenter, Randomized, Open Label, Parallel Study to Evaluate the Efficacy & Safety of IVF-M HP Inj. vs. Menopur® Inj.

Infertility, Female
LG Life Sciences

Unknown

BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 2000mg in Comparison to Each Component Administered Alone

Healthy

Korea, Republic of
Achieve Life Sciences

Completed

Safety Study of an Antisense Product in Prostate, Ovarian, NSCL, Breast or Bladder Cancer

Neoplasms

United States, Canada
LG Life Sciences

Completed

A Clinical Trial to Evaluate the Safety and Efficacy of Retreatment With Intra-articular LBSA0103 Injections in the Patients With Osteoarthritis of the Knee

Osteoarthritis of Knee

Korea, Republic of
LG Life Sciences

Completed

Pharmacokinetics and Safety Study of LBAL in Healthy Subjects

Healthy Subjects
LG Life Sciences

Completed

BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 500mg in Comparison to Each Component Administered Alone

Healthy

Korea, Republic of
LG Life Sciences

Completed

Pharmacokinetic Drug Interaction Study Between Gemigliptin and Irbesartan After Oral Administration in Healthy Male Subjects

Healthy

Korea, Republic of
LG Life Sciences

Completed

Influence of Hepatic Impairment on Pharmacokinetic (PK) and Pharmacodynamic (PD) of Gemigliptin PK and PD After Multiple Oral Doses in Healthy White Volunteers

Hepatic Impairment

Germany
LG Life Sciences

Completed

BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 1000mg in Comparison to Each Component Administered Alone.

Healthy

Korea, Republic of
LG Life Sciences

Completed

Study to Investigate the Safety and Pharmacokinetic Characteristics of LC28-0126 in Healthy Male Subjects

Healthy

Korea, Republic of
LG Life Sciences

Completed

Phase III Clinical Study to Evaluate the Efficacy and Safety of the Combination of Lercanidipine/Valsartan in Hypertensive Patients

Hypertension

Korea, Republic of
LG Life Sciences

Completed

A Phase III Study to Assess the Immunogenicity and Safety of Eutravac (DTap-HB Combined Vaccine) With DTaP and Hepatitis B Vaccines in Healthy Infants

Healthy Infants

Korea, Republic of
LG Life Sciences

Completed

Safety and Efficacy Study of LB80380 in the Treatment-naive Patients of Chronic Hepatitis B

Chronic Hepatitis B

Korea, Republic of, China
Achieve Life Sciences

Completed

Evaluation of Safety and Feasibility of OGX-011 in Combination With 2nd-line Chemotherapy in Patients With HRPC

Prostate Cancer

Canada

3

Subscribe